Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01269424
Title O6-Benzylguanine and Temozolomide With MGMTP140K Genetically Modified Blood Stem Cells in Untreated Glioblastoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Stanton Gerson MD
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland Ohio 44106-5047 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field